Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BTAI
#5120
BioXcel Therapeutics, Inc. - Common Stock
0.0
1
USD
-10.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-10.00%
Monthly Change
-98.91%
6 month change
-99.26%
Year Change
-99.26%
Previous Close
0.0
1
Open
0.0
1
Low
0.0
1
High
0.0
1
Volume
34
Markets
US Stock Market
Healthcare
BTAI
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
1.54 M
1.75 M
1.81 M
1.91 M
5.49 M
27.07 M
30.88 M
Valuation ratios
Enterprise value
922.15 M
335.87 M
521.87 M
124.97 M
105.47 M
99.57 M
118.46 M
Price to earnings ratio
—
-5.02
-3.63
-0.48
-0.25
-0.28
-0.24
Price to sales ratio
—
11.66 K
1 603.21
61.85
6.69
30.42
22.06
Price to cash flow ratio
—
6.53
4.44
0.55
0.21
-0.34
-0.25
Price to book ratio
—
2.42
7.83
1.51
0.16
-0.2
-0.04
Enterprise value to EBITDA ratio
-11.25
-3.15
-3.29
-0.73
-1.59
-2.57
-2.44
Profitability ratios
Return on assets %
-0.37
-0.45
-0.81
-2.43
-1.55
-1.56
-0.37
Return on equity %
-0.4
-0.48
-2.16
3.17
0.64
0.73
0.12
Return on invested capital %
-11.07 K
—
—
—
-12.89 K
-574.81
—
Gross margin %
100
100
94.67
8.7
5.43
74.45
-37.38
Operating margin %
-53.09 K
232.47 K
-42.57 K
-12.45 K
-2 967.56
-7 859.97
-4 962.62
EBITDA margin %
-52.87 K
231.92 K
-42.26 K
-12.33 K
-2 933.32
-7 555.92
-4 690.78
Net margin %
-53.01 K
232.46 K
-44.2 K
-12.97 K
-2 630.14
-10.89 K
-6 160.68
Liquidity ratios
Quick ratio
—
—
6.11
2.57
1.65
0.82
0.61
Current ratio
18.33
14.21
6.17
2.65
1.68
0.83
0.62
Inventory turnover
—
—
0.01
0.63
1.61
0.23
0.46
Asset turnover
0
-0
0
0.01
0.04
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
0.45
1.36
2.67
1.88
2.95
Debt to equity ratio
—
—
1.21
-1.78
-1.1
-0.89
-0.95
Long term debt to total assets ratio
—
—
0.45
1.36
2.67
2.44
2.95
Long term debt to total equity ratio
—
—
1.21
-1.78
-1.1
-1.15
-0.95
Per share metrics
Operating cash flow per share
—
-49.84
-77.3
-85.14
-28.41
-4.72
-4.59
EBIT per share
—
-64.85
-91.18
-94.36
-26.53
-4.13
-4.3
EBITDA per share
—
-64.72
-90.5
-93.43
-26.22
-3.97
-4.14
Total debt per share
—
—
53.14
55.26
40.44
6.94
4.25
Cash per share
—
141.34
110.64
35.82
11.78
2.33
0.73
Net current asset value per share
—
143.67
115.86
39.63
14.75
3.66
1.44
Tangible book value per share
—
134.48
43.85
-31.04
-36.73
-7.82
-4.48
Working capital per share
—
133.56
97.07
24.65
5.98
-0.76
-0.89
Book value per share
—
134.48
43.85
-31.04
-36.73
-7.82
-4.48
News
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
CorMedix (CRMD) Q1 Earnings and Revenues Beat Estimates
Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?
BioXcel Therapeutics stock initiated with buy rating at Rodman
BioXcel Therapeutics closes $8M registered direct offering
BioXcel Therapeutics raises $8M in registered direct offering
Why Are BioXcel Therapeutics Shares Down Friday? - BioXcel Therapeutics (NASDAQ:BTAI)
BioXcel reports positive Phase 2 data for opioid withdrawal drug
BioXcel Therapeutics Stock Rallies Opioid Study Success - BioXcel Therapeutics (NASDAQ:BTAI)
BioXcel Therapeutics announces milestone and retention bonuses for key executives
BioXcel Therapeutics submits application to expand IGALMI use for at-home treatment